Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study
Alimentary Pharmacology & Therapeutics · 2025-06 · 61 (12) · 1904-1912
DOI: 10.1111/apt.70162 ↗At a glance
Kohortenstudie in Alimentary Pharmacology & Therapeutics, published online on 2025-04-29. Written by Ramin Ebrahimi and 8 co-authors. Institution: Division of Cardiology, Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany. Major MEDLINE topics: Percutaneous Coronary Intervention, Inflammatory Bowel Diseases, Cardiovascular Diseases, Coronary Artery Bypass. Cited 13 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Bengt Ihre Research Fellowship, Margot und Erich Goldschmidt & Peter René Jacobson-Foundation.
Abstract (original language)
Background
Inflammatory bowel diseases ( IBD ) have been associated with an increased long‐term risk of coronary artery disease due to chronic systemic inflammation.
Aim
To evaluate the risk of major adverse cardiovascular events (MACE) after coronary interventions.
Methods
In this nationwide cohort study of adults undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) (2012–2022), patients with IBD were propensity score‐matched 1:10 to comparators without IBD. The primary outcome was MACE, a composite of acute myocardial infarction, stroke, hospitalisation for heart failure, or mortality. Secondary outcomes included each MACE component, 30‐day all‐cause readmission, revascularisation and in‐hospital outcomes including intensive care unit admission and length of hospital stay. We calculated hazard ratios (HRs) and incidence rates (IRs) using Cox proportional hazards modelling.
Results
We included 987 patients with IBD and 9571 matched comparators. After a median follow‐up of 3.5 years, MACE occurred in 488 patients with IBD (49.4%, IR: 96.5/10,000 person‐years [PY]) and in 3857 matched comparators (40.3%, IR: 68.9/10,000 PY); HR 1.37 (95% CI, 1.24–1.52). This equates to one additional MACE for every 36 patients with IBD over 10 years. The risk of each MACE component was increased, except for stroke. There were no differences between IBD subtypes or coronary intervention (PCI vs. CABG). Risks were highest in older individuals and elective interventions.
Conclusions
Patients with IBD were at 37% higher risk of MACE after coronary intervention, indicating a need for intensified cardiovascular risk reduction in these high‐risk individuals.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiology, Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Gastroenterology and Hepatology, University Digestive Health Care Center Basel-Clarunis, Basel, Switzerland.
- Department of Biomedicine, Gastroenterology Group, University of Basel, Basel, Switzerland.
- Division of Cardiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
ORCID profiles: Fahim Ebrahimi, Jan Hendrik Niess, Shaojie Chen, Weiwei Bian, Alexander Kutz, Anders Forss
Funding
- Bengt Ihre Research Fellowship
- Margot und Erich Goldschmidt & Peter René Jacobson-Foundation
Cite
APA
Ebrahimi, R., Ebrahimi, F., Niess, J. H., Mahdi, A., Chen, S., Di Vece, D., Bian, W., Kutz, A., & Forss, A. (2025). Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study. Alimentary Pharmacology & Therapeutics, 61(12), 1904-1912. https://doi.org/10.1111/apt.70162
Vancouver
Ebrahimi R, Ebrahimi F, Niess JH, Mahdi A, Chen S, Di Vece D, et al. Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study. Alimentary Pharmacology & Therapeutics. 2025;61(12):1904-1912. doi:10.1111/apt.70162
BibTeX
@article{Ebrahimi2025,
author = {Ebrahimi, Ramin and Ebrahimi, Fahim and Niess, Jan Hendrik and Mahdi, Ali and Chen, Shaojie and Di Vece, Davide and Bian, Weiwei and Kutz, Alexander and Forss, Anders},
title = {Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
volume = {61},
number = {12},
pages = {1904--1912},
doi = {10.1111/apt.70162}
}
EUVIMED